𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quantification of outpatient management and hospitalization of patients with high-risk myelodysplastic syndrome treated with low-dose decitabine

✍ Scribed by J. A. Pitako; P. S. Haas; J. Van den Bosch; H. Müller-Berndorff; A. Kündgen; U. Germing; P. W. Wijermans; M. Lübbert

Publisher
Springer
Year
2005
Tongue
English
Weight
114 KB
Volume
84
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prolonged complete remission of myelodys
Prolonged complete remission of myelodysplastic syndrome treated with danazol, retinoic acid and low-dose prednisone
✍ I. Sadek; E. Zayed; O. Hayne; L. Fernandez 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 2 views

Myelodysplastic syndrome (MDS) is a diverse group of clonal hematologic neoplasms. Different medications have been tried in MDS; however, no effective treatment has been yet established. We report a patient with MDS who achieved a complete remission in response to combination therapy of danazol, ret

A combination chemotherapy with low dose
A combination chemotherapy with low doses of cytarabine and etoposide for high risk myelodysplastic syndromes and their leukemic stage: A pilot study
✍ Shin-ichiro Kuriya; Kazunori Murai; Yasuro Miyairi; Taiju Utsugisawa; Yasushi Na 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

## BACKGROUND. Even now, no definitely effective therapy is inducted to high risk myelodysplastic syndromes (MDS) and their leukemic stage (MDS-AML) except bone marrow transplantation. ## METHODS. Ten patients with high risk MDS and 6 with MDS-AML were treated with daily low doses of cytarabine